The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Examining patient choices for metastatic breast cancer drugs.
Mary Lou Smith
No relevant relationships to disclose
Carol B White
No relevant relationships to disclose
Elda Railey
No relevant relationships to disclose
Anna Maria Storniolo
No relevant relationships to disclose
George W. Sledge
No relevant relationships to disclose